Inventor · disambiguated record
Scott M. Herbig
Also filed as: HERBIG SCOTT M · HERBIG SCOTT MAX · HERBIG Scott
23 granted patents·20 pending applications·1,572 citations·filing 1990–2022
97Inventor score
Top patents by PatentIndex Score
43 records- 0198US6706283B1Controlled release by extrusion of solid amorphous dispersions of drugsPFIZER·Filed 2000·Granted Mar 16, 2004·202 cites·71 claims
- 0296US5698220AAsymmetric membranes in delivery devicesPFIZER·Filed 1995·Granted Dec 16, 1997·264 cites·50 claims
- 0396US5612059AUse of asymmetric membranes in delivery devicesPFIZER·Filed 1992·Granted Mar 18, 1997·270 cites·41 claims
- 0495US8431159B2Solid pharmaceutical dispersions with enhanced bioavailabilityCURATOLO WILLIAM J·Filed 2012·Granted Apr 30, 2013·23 cites·16 claims
- 0595US6984403B2Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2004·Granted Jan 10, 2006·85 cites·48 claims
- 0695US5798119AOsmotic-delivery devices having vapor-permeable coatingsJOHNSON & SON INC S C·Filed 1995·Granted Aug 25, 1998·198 cites·42 claims
- 0794US8337899B2Solid pharmaceutical dispersions with enhanced bioavailabilityCURATOLO WILLIAM J·Filed 2012·Granted Dec 25, 2012·21 cites·12 claims
- 0893US8263128B2Solid pharmaceutical dispersions with enhanced bioavailabilityCURATOLO WILLIAM J·Filed 2001·Granted Sep 11, 2012·44 cites·23 claims
- 0993US8257741B2Solid pharmaceutical dispersions with enhanced bioavailabilityCURATOLO WILLIAM J·Filed 2003·Granted Sep 4, 2012·42 cites·16 claims
- 1092US5827538AOsmotic devices having vapor-permeable coatingsPFIZER·Filed 1994·Granted Oct 27, 1998·59 cites·28 claims
- 1190US8367118B2Solid pharmaceutical dispersions with enhanced bioavailabilityBEND RES INC·Filed 2012·Granted Feb 5, 2013·9 cites·12 claims
- 1286US7550158B2Controlled release by extrusion of solid amorphous dispersions of drugsBEND RES INC·Filed 2004·Granted Jun 23, 2009·19 cites·8 claims
- 1385US7887844B2Multiparticulate crystalline drug compositions having controlled release profilesPFIZER·Filed 2004·Granted Feb 15, 2011·16 cites·15 claims
- 1485US6517866B1Sertraline salts and sustained-release dosage forms of sertralinePFIZER·Filed 1998·Granted Feb 11, 2003·70 cites·116 claims
- 1584US10639309B2Tofacitinib oral sustained release dosage formsPFIZER·Filed 2018·Granted May 5, 2020·2 cites·25 claims
- 1684US9937181B2Tofacitinib oral sustained release dosage formsPFIZER·Filed 2014·Granted Apr 10, 2018·8 cites·25 claims
- 1783US6641840B2Sustained release formulations for growth hormone secretagoguesPFIZER·Filed 2001·Granted Nov 4, 2003·19 cites·3 claims
- 1881US5609590APH-triggered osmotic bursting delivery devicesPFIZER·Filed 1994·Granted Mar 11, 1997·56 cites·24 claims
- 1980US5603953ASupported liquid membrane delivery devicesPFIZER·Filed 1995·Granted Feb 18, 1997·58 cites·21 claims
- 2079US5358502APH-triggered osmotic bursting delivery devicesPFIZER·Filed 1993·Granted Oct 25, 1994·49 cites·14 claims
- 2170US2022142927A1Tofacitinib oral sustained release dosage formsPFIZER·Filed 2022·Application pending·0 cites
- 2270US2010003331A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2009·Application pending·0 cites
- 2369US5876752AUse of interfacially-polymerized membranes in delivery devicesPFIZER·Filed 1991·Granted Mar 2, 1999·36 cites·25 claims
- 2465US2015024054A1Solid pharmaceutical dispersions with enhanced bioavailabilityBEND RES INC·Filed 2014·Application pending·0 cites
- 2564US11253523B2Tofacitinib oral sustained release dosage formsPFIZER·Filed 2020·Granted Feb 22, 2022·0 cites·98 claims
- 2662US2013224301A1Solid pharmaceutical dispersions with enhanced bioavailabilityBEND RES INC·Filed 2013·Application pending·0 cites
- 2760US2008015343A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2007·Application pending·0 cites
- 2860US2007190129A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2004·Application pending·0 cites
- 2959US5091080AAdsorbents for the removal of volatile substances from aqueous systemsBEND RES INC·Filed 1990·Granted Feb 25, 1992·22 cites·18 claims
- 3058US2008299188A1Controlled release dosage forms combining immediate release and sustainted release of low-solubility drugPFIZER·Filed 2007·Application pending·0 cites
- 3157US2005158391A1Azithromycin multiparticulate dosage forms by melt-congeal processesPFIZER·Filed 2004·Application pending·0 cites
- 3256US2006029677A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2005·Application pending·0 cites
- 3356US2004208926A1Solubilized sertraline compositionsPFIZER·Filed 2004·Application pending·0 cites
- 3456US2006039988A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2005·Application pending·0 cites
- 3553US2004052845A1Hydrogel-driven drug dosage formFiled 2001·Application pending·0 cites
- 3653US2003086972A1Hydrogel-driven drug dosage formFiled 2001·Application pending·0 cites
- 3753US2008199527A1Enteric Coated Azithromycin MultiparticulatesPFIZER·Filed 2005·Application pending·0 cites
- 3852US2004121015A1Controlled-Release of an active substance into a high fat environmentPFIZER·Filed 2003·Application pending·0 cites
- 3951US2010233272A1Dosage forms comprising celecoxib providing both rapid and sustained pain reliefAPPEL LEAH ELIZABETH·Filed 2008·Application pending·0 cites
- 4048US2021401834A1Modified release formulations of modified forms of trimetazidineIMBRIA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4148US2004091530A1Sustained release formulations for growth hormone secretagoguesFiled 2003·Application pending·0 cites
- 4248US2011002989A1Methods, dosage forms and kits for administering ziprasidone without foodPFIZER·Filed 2009·Application pending·0 cites
- 4342US2008145427A1Dosage Forms Providing Controlled and Immediate Release of Cholesteryl Ester Transfer Protein Inhibitors and Immediate Release of Hmg-Coa Reductase InhibitorsBERCHIELLI ALFRED·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →